Ardelyx Inc (ARDX)
6.86
+0.08
(+1.18%)
USD |
NASDAQ |
May 31, 16:00
6.85
-0.01
(-0.15%)
After-Hours: 20:00
Ardelyx Free Cash Flow: -81.12M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
March 31, 2024 | -81.12M |
December 31, 2023 | -90.06M |
September 30, 2023 | -67.02M |
June 30, 2023 | -70.78M |
March 31, 2023 | -87.23M |
December 31, 2022 | -70.04M |
September 30, 2022 | -123.70M |
June 30, 2022 | -133.31M |
March 31, 2022 | -137.04M |
December 31, 2021 | -154.42M |
September 30, 2021 | -132.88M |
June 30, 2021 | -117.78M |
March 31, 2021 | -101.78M |
December 31, 2020 | -81.76M |
September 30, 2020 | -75.06M |
June 30, 2020 | -75.86M |
March 31, 2020 | -84.70M |
December 31, 2019 | -76.81M |
September 30, 2019 | -84.40M |
June 30, 2019 | -90.66M |
March 31, 2019 | -80.80M |
Date | Value |
---|---|
December 31, 2018 | -70.58M |
September 30, 2018 | -47.19M |
June 30, 2018 | -39.86M |
March 31, 2018 | -46.52M |
December 31, 2017 | -67.54M |
September 30, 2017 | -101.72M |
June 30, 2017 | -108.31M |
March 31, 2017 | -108.83M |
December 31, 2016 | -97.40M |
September 30, 2016 | -89.95M |
June 30, 2016 | -76.18M |
March 31, 2016 | -82.48M |
December 31, 2015 | -75.29M |
September 30, 2015 | -58.06M |
June 30, 2015 | -51.35M |
March 31, 2015 | 3.491M |
December 31, 2014 | 11.54M |
September 30, 2014 | 27.27M |
June 30, 2014 | 32.82M |
March 31, 2014 | 4.514M |
December 31, 2013 | 1.533M |
Free Cash Flow Range, Past 5 Years
-154.42M
Minimum
Dec 2021
-67.02M
Maximum
Sep 2023
-96.82M
Average
-85.97M
Median
Free Cash Flow Benchmarks
Alnylam Pharmaceuticals Inc | 127.82M |
Cytokinetics Inc | -421.55M |
Amicus Therapeutics Inc | -88.03M |
Insmed Inc | -588.55M |
Rigel Pharmaceuticals Inc | -6.82M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | -35.72M |
Cash from Investing (Quarterly) | -2.572M |
Cash from Financing (Quarterly) | 52.97M |
Free Cash Flow Per Share (Quarterly) | -0.1539 |
Free Cash Flow to Equity (Quarterly) | -85.88M |
Free Cash Flow to Firm (Quarterly) | -31.80M |
Free Cash Flow Yield | -5.21% |